MoneyWorks4Me

Gufic Biosciences - Quaterly Results

14 Feb 2025 Evaluate
A minor change in the total revenue was seen in the December 2024 quarter. The total revenue for the quarter stood at Rs. 2077.94 millions against Rs. 2017.78 millions during year ago period.Net profit declined -13.17% to Rs. 193.25 millions from Rs. 222.57 millions.Operating Profit reported a sharp decline to 358.07 millions from 368.79 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 2077.94 2017.78 2.98 6147.86 6116.72 0.51 8066.66 6906.21 16.80
Other Income 18.64 4.24 339.62 32.33 16.39 97.25 21.77 25.74 -15.42
PBIDT 358.07 368.79 -2.91 1115.82 1129.42 -1.20 1480.48 1372.25 7.89
Interest 49.09 31.79 54.42 147.12 117.13 25.60 153.60 82.23 86.79
PBDT 308.98 337.00 -8.31 968.70 1012.29 -4.31 1326.88 1290.02 2.86
Depreciation 46.18 41.42 11.49 132.21 126.75 4.31 170.17 222.81 -23.63
PBT 262.80 295.58 -11.09 836.49 885.54 -5.54 1156.71 1067.21 8.39
TAX 69.55 73.01 -4.74 216.89 224.63 -3.45 295.36 270.16 9.33
Deferred Tax 30.05 1.03 2817.48 32.39 33.92 -4.51 31.66 -11.94 -365.16
PAT 193.25 222.57 -13.17 619.60 660.91 -6.25 861.35 797.05 8.07
Equity 100.28 100.28 0.00 100.28 100.28 0.00 100.28 96.94 3.45
PBIDTM(%) 17.23 18.28 -5.72 18.15 18.46 -1.70 18.35 19.87 -7.63
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..